Tafamidis: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

23 April 2024

22 April 2024

17 April 2024

21 March 2024

20 March 2024

10 March 2024

20 December 2023

12 December 2023

25 October 2023

25 August 2023

12 May 2023

23 March 2023

4 March 2023

2 March 2023

4 November 2022

1 June 2022

30 May 2022

26 November 2021

20 August 2021

2 August 2021

10 July 2021

30 June 2021

7 June 2021

4 June 2021

  • curprev 11:2311:23, 4 June 2021Shinryuu talk contribs 17,176 bytes +108 Revised first paragraph: depending on the label, tafamidis can be used to treat ATTR with cardiomyopathy or polyneuropathy, regardless of whether it is the hereditary form (hATTR) or the wild-type form (wtATTR). undo

12 December 2020

24 September 2020

17 September 2020

15 September 2020

17 August 2020

6 August 2020

1 April 2020

23 December 2019

20 December 2019

19 December 2019

25 November 2019

23 July 2019

1 June 2019

30 May 2019

8 May 2019

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)